Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2010
03/18/2010WO2009108252A3 Method for stimulating immune response against moraxella catarrhalis
03/18/2010WO2005042711A9 Pain-associated gene pnpg1
03/18/2010US20100071097 Nucleic Acid Molecules and Other Molecules Associated with the Methionine Synthesis and Degradation Pathways
03/18/2010US20100071094 Promoter expressed in the dehiscence zone of dry fruits
03/18/2010US20100071093 Yield Increase in Plants Overexpressing the ACCDP Genes
03/18/2010US20100071091 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
03/18/2010US20100071089 Method For Increasing Pathogen Resistance In Transgenic Plants
03/18/2010US20100071088 Plant Expression Constructs and Methods of Utilizing Same
03/18/2010US20100071087 Enhanced floral sink strength and increased stability of seed set in plants
03/18/2010US20100071085 System for Expression of Genes in Plants from a Virus-Based Expression Vector
03/18/2010US20100071084 Potexvirus-derived replicon
03/18/2010US20100069624 Nucleic Acid Mediated Electron Transfer
03/18/2010US20100069623 Method for preparing oligonucleotides
03/18/2010US20100069622 siRNA targeting amyloid beta (A4) precursor protein (APP)
03/18/2010US20100069621 Polynucleotides and related nanoassemblies, structures, arrangements, methods and systems
03/18/2010US20100069620 Novel compositions of chemically modified small interfering rna
03/18/2010US20100069611 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target
03/18/2010US20100069606 Tubular nanostructure targeted to cell membrane
03/18/2010US20100069472 Compositions and their uses directed to huntingtin
03/18/2010US20100069471 Chemically modified oligonucleotides
03/18/2010US20100069465 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
03/18/2010US20100069464 Compositions and methods for modulating activity of capped small rnas
03/18/2010US20100069462 Mitochondrial function of prohibitin 2 (phb2)
03/18/2010US20100069461 Compositions and methods for inhibiting expression of factor v leiden mutant gene
03/18/2010US20100069334 Diagnostic method
03/18/2010US20100069321 Biological Materials and Uses Thereof
03/18/2010US20100069300 C-Type Lectin Fold as a Scaffold for Massive Sequence Variation
03/18/2010US20100069263 Sequence tag directed subassembly of short sequencing reads into long sequencing reads
03/18/2010US20100069261 siRNA targeting proto-oncogene MET
03/18/2010US20100069260 Compositions and methods for the identification of inhibitors of protein synthesis
03/18/2010US20100069258 Hydrophilic Labels for Biomolecules
03/18/2010US20100069256 Markers and Methods for Assessing and Treating Ulcerative Colitis and Related Disorders Using a 20 Gene Panel
03/18/2010US20100069250 Digital PCR Calibration for High Throughput Sequencing
03/18/2010US20100068814 Multi-microrna methods and compositions
03/18/2010US20100068807 INTERFERON-alpha REGULATOR
03/18/2010US20100068806 Novel methods and reagents directed to production of cells
03/18/2010US20100068803 Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof
03/18/2010US20100068802 Novel human androgen receptor alternative splice variants as biomarkers and therapeutic targets
03/18/2010US20100068773 Microbiological production of 3-hydroxyisobutyric acid
03/18/2010US20100068766 Composition for cleaving and/or connecting single strand dna
03/18/2010US20100068763 Mammalian chemokines; receptors; reagents; uses
03/18/2010US20100068762 Novel nucleic acid molecules
03/18/2010US20100068761 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains
03/18/2010US20100068760 Proteins with esterase activity
03/18/2010US20100068759 Modified chondroitin synthase polypeptide and crystal thereof
03/18/2010US20100068742 Methods
03/18/2010US20100068732 Cloned glucagon-like peptide-2 receptors
03/18/2010US20100068722 increase the intensity of the fluorescent signal after nucleic acid sequencing reactions; a modified fluorescent labelled guanine-containing nucleotides which exhibit enhanced fluorophore intensity
03/18/2010US20100068718 Methods and Compositions for Identifying Yeast
03/18/2010US20100068713 Probe for detecting mutation in jak2 gene and use thereof
03/18/2010US20100068712 Oligonucleotides for use in allele-specific pcr
03/18/2010US20100068704 Oligonucleotides comprising signalling pairs and hydrophobic nucleotides, stemless beacons, for detection of nucleic acids, methylation status and mutants of nucleic acids
03/18/2010US20100068335 Phytases with improved thermal stability
03/18/2010US20100068229 Recombinant antigens of human cytomegalovirus (hcmv)
03/18/2010US20100068228 Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid Compositions
03/18/2010US20100068226 Polynucleotides and Uses Thereof
03/18/2010US20100068219 Peptides that mimic non-human cross-reactive protective epitopes of the group b meningococcal capsular polysaccharide
03/18/2010US20100068218 Optimized Multi-Epitope Constructs and Uses Thereof
03/18/2010US20100068217 Epitope-transplant scaffolds and their use
03/18/2010US20100068214 Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus
03/18/2010US20100068208 Degranulation inhibitor
03/18/2010US20100068207 DDR2 in Cancer Diagnosis, Detection and Treatment
03/18/2010US20100068199 Pcsk9 antagonists
03/18/2010US20100068198 Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in the treatment of proliferative diseases
03/18/2010US20100068173 Recombinant Human Albumin-Interleukin-11 Fusion Protein With Long-Lasting Biological Effects
03/18/2010US20100068172 Nematode Control
03/18/2010US20100068145 Bispecific fusion protein having therapeutic and diagnostic potential
03/18/2010US20100068135 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
03/18/2010CA2735197A1 Imaging individual mrna molecules using multiple singly labeled probes
03/17/2010EP2163653A2 Nucleic acid detection method having increased sensitivity
03/17/2010EP2163652A1 Preparing crude biological extracts using protease, suitable for preparing cDNA
03/17/2010EP2163651A1 Method of detecting and quantifying hepatitis C virus
03/17/2010EP2163643A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
03/17/2010EP2163642A1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis
03/17/2010EP2163560A2 Compositions and methods using RNA interference for control of nematodes in plants
03/17/2010EP2163556A1 Polyanion for improved nucleic acid amplification
03/17/2010EP2162538A2 Hydroxymethyl substituted rna oligonucleotides and rna complexes
03/17/2010EP2162459A1 Transcriptomic biomarkers for individual risk assessment in new onset heart failure
03/17/2010EP1766075B1 Method for nucleic acid analysis
03/17/2010EP1664300B1 A new class of a2delta calcium channel subunits
03/17/2010EP1660674B1 Expression profiling using microarrays
03/17/2010EP1594981B1 Double ended sequencing
03/17/2010CN101675066A Method for inhibiting scavenger receptor-a and increasing immune response to antigens
03/16/2010US7680601 Generating antibiotic; transforming cell with expression vector coding polyketide synthase; computational analysis of polyketides and computer-assisted design of PKS genes are facilitated by representing structure of polyketide and/or PKS gene that encodes PKS that produces polyketide
03/16/2010US7678897 RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)
03/16/2010US7678896 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
03/16/2010US7678895 oligonucleotide with modified phosphorothioate linkage, sugar moiety, or nucleobase; disease or condition associated with expression of superoxide dismutase 1
03/16/2010US7678894 comprise a label attached to the nitrogenous base portion of the analog via a cleavable linker at the N4, O4, N6 or O6 position; reversible inhibitors or blockers that allow the incorporation of only one nucleotide per addition cycle in a template-dependent sequencing-by-synthesis reaction
03/16/2010US7678893 Fluorescent proteins from Copepoda species and methods for using same
03/16/2010US7678892 Dye-labeled ribonucleotide triphosphates
03/16/2010US7678824 Methods for treatment with bucindolol based on genetic targeting
03/16/2010US7678569 Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof
03/16/2010US7678560 Δ 5 desaturase and its use in making polyunsaturated fatty acids
03/16/2010US7678558 Method for overexpression of zwitterionic polysaccharides
03/16/2010US7678557 Producing Oligoribonucleotides (ORNs) that are stress response factors from bacteria as immunostimulants for use suppressing microbial infections and the onset of endotoxic shock; feed supplements for livestock
03/16/2010US7678554 Nucleic acid shuffling
03/16/2010US7678542 Charge tags and the separation of nucleic acid molecules
03/16/2010US7678541 Methods and compositions for the detection of a nucleic acid using a non-invasive cleavage reaction
03/16/2010CA2087817C 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use
03/11/2010WO2010028079A2 Synthetic methods and derivatives of triphosphate oligonucleotides